Machine learning helps determine success of advanced genome editing
A new tool to predict the chances of successfully inserting a gene-edited sequence of DNA into the genome of a cell, using a technique known as prime editing, has been developed by researchers at the Wellcome Sanger Institute.
Maxion Therapeutics announces the completion of its USD $16 million Series A financing
The funds will be used to support the development of novel biologics targeting ion channels and G-protein-coupled receptors (GPCRs) via Maxion’s KnotBody® platform.
Cresset February 2023 Newsletter
After another busy month, our February monthly update newsletter includes features around Spark database updates, protein degradation therapeutics, and more!
It’s onwards and upwards for ATM Steel thanks to Haverhill’s EpiCentre
ATM Steel attributes a key part of its rapid expansion to the flexible service provided by the EpiCentre in Haverhill where it has been located for two years.
Arecor granted patents in India and the United States protecting proprietary formulations of differentiated biopharmaceutical products
Patents further strengthen Group’s extensive patent portfolio protecting its proprietary diabetes portfolio and demonstrate potential of innovative Arestat™ technology in development of enhanced formulations of high value biologics
Astex and Cardiff University Medicines Discovery Institute Announce New Drug Discovery Collaboration on Neurodegenerative Diseases
Astex Pharmaceuticals (UK) (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system and The Medicines Discovery Institute, Cardiff University (“MDI”) announced today that they have e
CIIPM 7 'The impact of AI on information, innovation and IP.'
The 7th CIIPM meeting features talks from five experts who will share their knowledge on topics including IP valuation, standard essential patents, AI for patent searching, patenting at the USPTO, and IP aspects of collaborative working.
The UK’s biggest business survey is back and it’s time to make your voice heard
Cambridgeshire Chambers of Commerce's Quarterly Economic Survey is back and once again they are asking you to contribute to one of the UK’s largest and most reputable barometers of business opinion.
PRO Organises Roundtable With George Freeman, Science & Innovation Minister
The PR Office was joined by George Freeman MP, the Minister for Science, Research, Technology & Innovation at the newly created Department for Science, Innovation and Technology to talk to some of the most innovative and exciting companies in the world. Today, the Minister heard first-hand from those at the forefront of #biotech, #datacentres, #medtech, #robotics, #ai, #deepdata, and next…
Bio-Rad Introduces StarBright Blue and StarBright Yellow Dyes to Enhance Multiplex Flow Cytometry
StarBright Blue and StarBright Yellow Dyes Conjugated to Highly Validated Antibodies for Conventional and Full Spectrum Flow Cytometry in Immunology Research
Professor Matt Hurles appointed Director of the Wellcome Sanger Institute
Following a comprehensive global search process, which began in February 2022, the Genome Research Limited Board announces the appointment of Professor Matt Hurles as the new Director of the Wellcome Sanger Institute.
Recent design work - new corporate brochure designed by Sable & Hawkes
Sable & Hawkes have recently worked on the design and development of Metrion Biosciences new corporate brochure.
Winner of global software competition donates prize to Addenbrooke’s charity
A software engineer generously donated part of his winnings from a worldwide software development challenge to give back to his local hospital, Addenbrooke’s.
Leading fragrance developer trusts in Habit Action to deliver their flagship HQ
Founded in 2006, Laurelle London is a market leader in the development, formulations, and supply of fragrance and beauty products as well as its own portfolio of brands.
CPFT partners largest ever UK trial of mental health treatment for young people
CPFT staff have successfully bid to run a £2.1 million national study, funded by the National Institute for Health and Care Research (NIHR), to investigate how more mental health practitioners can deliver effective interventions to support young people’s mental health.
H.E.L Group appoints Allen Wang as General Manager of H.E.L China
Appointment follows successful expansion of operations in China and transition to direct sales model Supports next phase in H.E.L’s development as China becomes significant contributor to commercial growthH.E.L Group (H.E.L), a global developer
Skills for life: National Apprenticeship Week
Cambridge University Hospitals NHS Foundation Trust says...we’re sharing the stories of some of our apprentices as part of National Apprenticeship Week — and celebrating the positive impact they make to staff and patients at our hospitals.
Spinout develops open-source software for the pharmaceutical industry
A group of university research scientists has formed a startup to adapt open-source academic chemical software for use in the pharmaceutical industry.
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems
RSV older adult, elderly vaccines - durability versus combination?
This month VacZine Analytics, a UK-based strategic research publisher exclusively focused on vaccines and infectious diseases, releases a new updated global demand analysis for RSV older adult, elderly vaccines.
Evonetix closes $24 million USD (£20 million) financing
Oversubscribed round led by Foresite Capital Funding will enable development of DNA synthesis chip technology to commercial scaleEVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today a
Glyconics© novel non-invasive diabetes screening device meets primary endpoints in two clinical investigations
Award-winning medtech firm, Glyconics© has successfully completed two independent clinical studies to validate the performance and safety of its novel non-invasive diabetes screening device.
Portuguese fertility doctors visit Bourn Hall, the birthplace of IVF treatment
Bourn Hall was delighted to welcome a delegation of Portuguese doctors from leading medical centres to its Cambridge clinic.